Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid

Protein Science

Volumn 14, Issue 1, 2005, Pages 231-239

  Koo, Bon W ^a   Miranker, Andrew D ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Amylin; Amyloid; Islet amyloid polypeptide; Protein folding; Secondary nucleation, phase mediated fibrillogenesis; Type II diabetes

Indexed keywords

AMYLIN; DISULFIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; KINETICS; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMINO ACID SEQUENCE; AMYLOID; DISULFIDES; KINETICS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS;

EID: 11144243803     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.041051205     Document Type: Article

References (25)

1. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C.M., and Stefani, M. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416: 507-511.
2. Chien, P. and Weissman, J.S. 2001. Conformational diversity in a yeast prion dictates its seeding specificity. Nature 410: 223-227.
3. Chien, P., DePace, A.H., Collins, S.R., and Weissman, J.S. 2003. Generation of prion transmission barriers by mutational control of amyloid conformations. Nature 424: 948-951.
4. Come, J.H., Fraser, P.E., and Lansbury Jr., P.T. 1993. A kinetic model for amyloid formation in the prion diseases: Importance of seeding. Proc. Natl. Acad. Sci. 90: 5959-5963.
5. DePace, A.H. and Weissman, J.S. 2002. Origins and kinetic consequences of diversity in Sup35 yeast prion fibers. Nat. Struct. Biol. 9: 389-396.
6. Eanes, E.D. and Glenner, G.G. 1968. X-ray diffraction studies on amyloid filaments. J. Histochem. Cytochem. 16: 673-677.
7. Gazit, E. 2002. A possible role for pi-stacking in the self-assembly of amyloid fibrils. FASEB J. 16: 77-83.
8. Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Muller, S.A., Kistler, J., Cooper, G.J., and Aebi, U. 2000. Amyloid fibril formation from full-length and fragments of amylin. J. Struct. Biol. 130: 352-362.
9. Green, J.D., Goldsbury, C., Kistler, J., Cooper, G.J., and Aebi, U. 2004. Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J. Biol. Chem. 279: 12206-12212.
10. Hall, D. and Edskes, H. 2004. Silent prions lying in wait: A two-hit model of prion/amyloid formation and infection. J. Mol. Biol. 336: 775-786.
11. Harper, J.D. and Lansbury Jr., P.T. 1997. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66: 385-407.
12. Higham, C.E., Jaikaran, E.T., Fraser, P.E., Gross, M., and Clark, A. 2000. Preparation of synthetic human islet amyloid polypeptide (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett. 470: 55-60.
13. Kahn, S.E., Andrikopoulos, S., and Verchere, C.B. 1999. Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes 48: 241-253.
14. Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brunner, H., Voelter, W., and Kapurniotu, A. 1999. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287: 781-796.
15. Kubelka, J., Hofrichter, J., and Eaton, W.A. 2004. The protein folding "speed limit". Curr. Opin. Struct. Biol. 14: 76-88.
16. Lakowicz, J.R. and Maliwal, B.P. 1983. Oxygen quenching and fluorescence depolarization of tyrosine residues in proteins. J. Biol. Chem. 258: 4794-4801.
17. O'Nuallain, B., Williams, A.D., Westermark, P., and Wetzel, R. 2004. Seeding specificity in amyloid growth induced by heterologous fibrils. J. Biol. Chem. 279: 17490-17499.
18. Oosawa, F. and Asakura, S. 1975. Thermodynamics of the polymerization of protein, p. 49. Academic Press, London, New York.
19. Padrick, S.B. and Miranker, A.D. 2001. Islet amyloid polypeptide: Identification of long-range contacts and local order on the fibrillogenesis pathway. J. Mol. Biol. 308: 783-794.
20. -. 2002. Islet amyloid: Phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41: 4694-4703.
21. Plaxco, K.W. and Dobson, C.M. 1996. Time-resolved biophysical methods in the study of protein folding. Curr. Opin. Struct. Biol. 6: 630-636.
22. Rochet, J.C. and Lansbury Jr., P.T. 2000. Amyloid fibrillogenesis: Themes and variations. Curr. Opin. Struct. Biol. 10: 60-68.
23. Santoso, A., Chien, P., Osherovich, L.Z., and Weissman, J.S. 2000. Molecular basis of a yeast prion species barrier. Cell 100: 277-288.
24. Serio, T.R., Cashikar, A.G., Kowal, A.S., Sawicki, G.J., Moslehi, J.J., Serpell, L., Arnsdorf, M.F., and Lindquist, S.L. 2000. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289: 1317-1321.
25. Sunde, M. and Blake, C. 1997. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50: 123-159.